Literature DB >> 10197758

Non-volatile general anaesthetics reduce spinal activity by suppressing plateau potentials.

P A Guertin1, J Hounsgaard.   

Abstract

Non-volatile general anaesthetics are thought to reduce brain activity by potentiating inhibitory GABA(A) receptor channels but also cause adverse effects by suppress ing L-type calcium channels in the heart. In sections of the spinal cord, the non-volatile anaesthetics pentobarbital, thiopental and propofol reduced excitability of sensorimotor neurons by suppressing plateau potentials mediated by L-type calcium channels. This effect was independent of GABA(A) receptor potentiation but occurred in an overlapping concentration range. Therefore, the suppressive effect of non-volatile anaesthetics on L-type calcium channels can contribute to the reduction of spinal sensorimotor activity during anaesthesia. The results support the idea that general anaesthesia is achieved through several mechanisms and suggest that procedures for anaesthesia may be improved by combining selective agents for each mechanism in optimal concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197758     DOI: 10.1016/s0306-4522(98)00371-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Variable amplification of synaptic input to cat spinal motoneurones by dendritic persistent inward current.

Authors:  H Hultborn; M Enríquez Denton; J Wienecke; J B Nielsen
Journal:  J Physiol       Date:  2003-09-18       Impact factor: 5.182

2.  Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats.

Authors:  P J Harvey; Y Li; X Li; D J Bennett
Journal:  J Neurophysiol       Date:  2005-11-09       Impact factor: 2.714

3.  Afterhyperpolarization-firing rate relation of turtle spinal neurons.

Authors:  E K Stauffer; D G Stuart; J C McDonagh; T G Hornby; R M Reinking
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2004-12-10       Impact factor: 1.836

4.  Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.

Authors:  Grzegorz Kwolek; Agnieszka Zakrzeska; Eberhard Schlicker; Manfred Göthert; Grzegorz Godlewski; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

5.  Nitrous oxide can enhance the hypnotic effect, but not the suppression of spinal motor neuron excitability by propofol in humans.

Authors:  Manabu Kakinohana; Yuji Miyata; Hiroshi Tomiyama; Kazuhiro Sugahara
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

6.  The afterhyperpolarization conductance exerts the same control over the gain and variability of motoneurone firing in anaesthetized cats.

Authors:  Marin Manuel; Claude Meunier; Maud Donnet; Daniel Zytnicki
Journal:  J Physiol       Date:  2006-08-24       Impact factor: 5.182

7.  Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis.

Authors:  Nicolas Delestrée; Marin Manuel; Caroline Iglesias; Sherif M Elbasiouny; C J Heckman; Daniel Zytnicki
Journal:  J Physiol       Date:  2014-01-20       Impact factor: 5.182

8.  Analysis of motoneuron responses to composite synaptic volleys (computer simulation study).

Authors:  Maria Piotrkiewicz; Lydia Kudina
Journal:  Exp Brain Res       Date:  2011-12-24       Impact factor: 1.972

9.  Clinical and physiological effects of transcranial electrical stimulation position on motor evoked potentials in scoliosis surgery.

Authors:  Yl Lo; Yf Dan; Ye Tan; A Teo; Sb Tan; Wm Yue; Cm Guo; S Fook-Chong
Journal:  Scoliosis       Date:  2010-02-23

10.  Does elimination of afferent input modify the changes in rat motoneurone properties that occur following chronic spinal cord transection?

Authors:  Duane C Button; Jayne M Kalmar; Kalan Gardiner; Tanguy Marqueste; Hui Zhong; Roland R Roy; V Reggie Edgerton; Phillip F Gardiner
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.